Ziqiang Cheng

Title: Ziqiang Cheng: Innovator in Pharmaceutical Development

Introduction

Ziqiang Cheng is a notable inventor based in Shanghai, China, recognized for his contributions to the pharmaceutical sector. With two patents to his name, his work focuses on developing innovative compounds that target critical pathways in disease treatment, particularly in oncology.

Latest Patents

Cheng's latest patent, titled "1-Isopropyl-3-methyl-8-(pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c] cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (ATM) kinase and uses thereof," introduces novel substituted imidazo[4,5-c]cinnolin-2-one compounds. This patent describes how these compounds selectively modulate the ATM kinase, providing insights into treating ATM-associated diseases, including various cancers.

Another significant patent, "Quinazoline derivatives as antitumor agents," discusses new quinazoline compounds that act as inhibitors for type I receptor tyrosine kinases. This innovation is crucial for formulating pharmaceutical compositions that aim to treat hyperproliferative diseases such as cancer and inflammation in humans.

Career Highlights

Ziqiang Cheng currently conducts his innovative work at Suzhou Zanrong Pharma Limited. His role at this company allows him to contribute significantly to drug development, focusing on therapies that can potentially change cancer treatment protocols. Cheng's dedication to advancing pharmaceutical science through his inventions marks him as a key player in this field.

Collaborations

In his professional journey, Cheng has collaborated closely with his coworker Ding Zhou. Together, they have worked on developing new therapeutic solutions, combining their expertise to foster innovation in drug delivery and efficacy.

Conclusion

Ziqiang Cheng's patent portfolio and collaborative efforts reflect his commitment to advancing medical science through innovative pharmaceutical solutions. His research not only contributes to the body of knowledge in the field but also holds promise for improving treatments available for complex diseases such as cancer. Cheng's work continues to inspire advancements within the pharmaceutical industry, revealing the power of dedicated inventors in shaping future healthcare solutions.